FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/04/032801 [Registered on: 13/04/2021] Trial Registered Prospectively
Last Modified On: 12/04/2022
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Research to study the benefits of additional local antibiotic to conservative therapy for healing of painful cuts in back passage  
Scientific Title of Study   A case control comparative study comparing the benefit of adding local and short term antibiotics to local analgesic and vasodilators in patients of anal fissures 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Krishna Gopal 
Designation  Additional Professor 
Affiliation  Indira Gandhi Institute of Medical Sciences (IGIMS), Patna 
Address  Department of Surgery Indira Gandhi Institute of Medical Sciences Sheikhpura Patna

Patna
BIHAR
800014
India 
Phone  8294155575  
Fax    
Email  gopakrishh@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vivek Kumar Roy 
Designation  Assistant Professor 
Affiliation  Indira Gandhi Institute of Medical Sciences (IGIMS), Patna 
Address  Department of Surgery Indira Gandhi Institute of Medical Sciences Sheikhpura Patna

Patna
BIHAR
800014
India 
Phone  9801716613  
Fax    
Email  roykanu23@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vivek Kumar Roy 
Designation  Assistant Professor 
Affiliation  Indira Gandhi Institute of Medical Sciences (IGIMS), Patna 
Address  Department of Surgery Indira Gandhi Institute of Medical Sciences Sheikhpura Patna

Patna
BIHAR
800014
India 
Phone  9801716613  
Fax    
Email  roykanu23@gmail.com  
 
Source of Monetary or Material Support  
Indira Gandhi Institute of Medical Sciences, Patna (Medical College and Hospital) 
 
Primary Sponsor  
Name  Dr Gopal Krishna 
Address  Department of Surgery IGIMS Sheikhpura Patna Bihar 800014 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vivek Kumar Roy  IGIMS  Department of Surgery Indira Gandhi Institute of Medical Sciences Sheikhpura
Patna
BIHAR 
9801716613

roykanu23@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IGIMS Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K602||Anal fissure, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  2% lignocaine gel with 0.2% nifedipine ointment  One fingertip unit of each to be applied locally in anus with applicator three times daily for 6 weeks 
Intervention  Metronidazole 1% ointment in addition to 2% lignocaine gel with 0.2% nifedipine ointment  One fingertip unit of each to be applied locally in anus with applicator three times daily for 6 weeks 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1. patients with clinical diagnosis of anal fissure
2. lesions limited to the epithelium,
3. patients who has pain in the anal region together with ulcers
4. Ulcer in the posterior anoderm without any skin tags
5. Consenting patients willing to voluntarily take part in this study after getting detailed information 
 
ExclusionCriteria 
Details  1. Presumed or confirmed pregnancy
2. Lactating women
3. History of reaction or intolerance to topical agents
4. Associated co-morbidity, such as ischemic heart disease, hypertension,chronic obstructive pulmonary disease, diabetes mellitus, inflammatory bowel disease, HIV- related fissure, tuberculosis ulcer and leukemic ulcer; and associated complications warranting surgery (abscess, fistula, haemorrhoids, and cancer)
 
 
Method of Generating Random Sequence   Stratified block randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Recovery rate  3rd week and 6th week of treatment 
 
Secondary Outcome  
Outcome  TimePoints 
VAS score  1st week, 3rd week and 6th week of starting treatment  
 
Target Sample Size   Total Sample Size="216"
Sample Size from India="216" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   18/04/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Closed to Recruitment of Participants 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
Anal fissure is one of the most common presenting complaints in the outpatient departments of general surgery. It is a well-recognized cause of acute anal pain. Although the exact pathophysiology is not yet elucidated but subclinical infection is hypothesized to be associated with chronic anal fissure. In previous studies addition of both oral and local antibiotics to conservative management benefited the patients with both acute and chronic anal fissure. 
Hypothesis: addition of local antibiotic to conservative management may hasten and improve recovery rate
Local vasodilator and analgesic or anaesthetic have proven benefits in both acute and chronic anal fissure. To evaluate whether addition of local antibiotic has any added advantage in terms of recovery and patient’s satisfaction this present study is undertaken. 

Patients of acute anal fissure were recruited after obtaining informed consent. Randomized as per allocation sequence done. 68 patients are recruited.
 
Close